EDITNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Editas Medicine, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$2.42+0.07 (+2.98%)
Close on Oct 19, 2026
- Market cap
- $288.69M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$40.52MFY2025, +23.5% a year since FY2016